- Home
- EPM vs ZURA Comparison
EPM vs ZURA Comparison
Compare EPM & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- ZURA
- Stock Information
- Founded
- EPM 2003
- ZURA 2022
- Country
- EPM United States
- ZURA United States
- Employees
- EPM N/A
- ZURA N/A
- Industry
- EPM Oil & Gas Production
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EPM Energy
- ZURA Health Care
- Exchange
- EPM Nasdaq
- ZURA Nasdaq
- Market Cap
- EPM 154.4M
- ZURA 137.2M
- IPO Year
- EPM 1996
- ZURA N/A
- Fundamental
- Price
- EPM $3.76
- ZURA $3.68
- Analyst Decision
- EPM Hold
- ZURA Strong Buy
- Analyst Count
- EPM 1
- ZURA 9
- Target Price
- EPM $4.50
- ZURA $11.38
- AVG Volume (30 Days)
- EPM 361.2K
- ZURA 495.3K
- Earning Date
- EPM 11-11-2025
- ZURA 11-13-2025
- Dividend Yield
- EPM 12.44%
- ZURA N/A
- EPS Growth
- EPM N/A
- ZURA N/A
- EPS
- EPM N/A
- ZURA N/A
- Revenue
- EPM $85,232,000.00
- ZURA N/A
- Revenue This Year
- EPM N/A
- ZURA N/A
- Revenue Next Year
- EPM $1.13
- ZURA N/A
- P/E Ratio
- EPM N/A
- ZURA N/A
- Revenue Growth
- EPM N/A
- ZURA N/A
- 52 Week Low
- EPM $3.86
- ZURA $0.97
- 52 Week High
- EPM $6.14
- ZURA $4.68
- Technical
- Relative Strength Index (RSI)
- EPM 20.69
- ZURA 48.99
- Support Level
- EPM $4.35
- ZURA $3.78
- Resistance Level
- EPM $4.60
- ZURA $4.10
- Average True Range (ATR)
- EPM 0.13
- ZURA 0.32
- MACD
- EPM -0.05
- ZURA -0.06
- Stochastic Oscillator
- EPM 5.06
- ZURA 23.80
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.